Welcome to our dedicated page for Alphatec Hldgs SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching for the most recent Alphatec Holdings insider trading Form 4 transactions or trying to decode an FDA comment buried deep in a 10-K? Investors often start with a single question—yet end up juggling hundreds of pages about spinal-implant clearances, surgeon partnerships, and R&D milestones. Our SEC filings hub puts every document in context, so you can focus on the implications for spinal-surgery innovation rather than on document hunting.
Each new Alphatec Holdings quarterly earnings report 10-Q filing arrives on Stock Titan within seconds of hitting EDGAR. AI then produces a concise Alphatec Holdings earnings report filing analysis, flags segment revenue shifts, and links directly to tables that matter to spine-device margins. Prefer real-time governance data? Alphatec Holdings Form 4 insider transactions real-time alerts track when surgeon-directors buy or sell shares—perfect for spotting confidence signals before product launches.
Need a high-level view? Start with Alphatec Holdings annual report 10-K simplified summaries that unpack R&D spend, FDA pathways, and competitive positioning. For event-driven traders, Alphatec Holdings 8-K material events explained highlights new product approvals and litigation updates within minutes. If compensation trends guide your valuation models, the Alphatec Holdings proxy statement executive compensation section is mapped to historical pay metrics. And if you just want the facts, "understanding Alphatec Holdings SEC documents with AI" quickly answers natural-language queries like “How much did R&D grow?” while “Alphatec Holdings SEC filings explained simply” gives plain-English context.
From compliance alerts to in-depth analysis, our platform turns Alphatec Holdings executive stock transactions Form 4 data and every other filing type into actionable spinal-tech insight—so you spend your time on decisions, not document searches.
What this filing shows
The filing notifies a proposed sale of 16,666 Alphatec Holdings (ATEC) common shares by an insider through Morgan Stanley Smith Barney, with an aggregate market value of $247,823.42. The sale is slated for 08/05/2025 on NASDAQ.
Why it matters
The shares being sold were granted as performance stock units (8,624) and restricted stock units (8,042). The filer, Scott Lish, has completed multiple recent sales under trading plans, totaling 136,022 shares sold in the past three months for gross proceeds of $1,721,457.50. This is a disclosure of insider liquidity events and shows pre-planned sales activity rather than new purchases.
FAQ
What is the current stock price of Alphatec Hldgs (ATEC)?
What is the market cap of Alphatec Hldgs (ATEC)?
